Jazz Pharmaceuticals plc (JAZZ)

Jazz Pharmaceuticals Revenue

Jazz Pharmaceuticals had revenue of $1.05B in the quarter ending September 30, 2024, with 8.52% growth. This brings the company's revenue in the last twelve months to $3.99B, up 5.23% year-over-year. In the year 2023, Jazz Pharmaceuticals had annual revenue of $3.83B with 4.78% growth.

• Revenue (ttm): $3.99B
• Revenue Growth: +5.23%
• P/S Ratio: 2.12
• Revenue / Employee: $1,425,969
• Employees: 2,800
• Market Cap: 8.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.83B	174.83M	4.78%
Dec 31, 2022	3.66B	565.14M	18.26%
Dec 31, 2021	3.09B	730.67M	30.91%
Dec 31, 2020	2.36B	201.81M	9.34%
Dec 31, 2019	2.16B	270.84M	14.32%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.